EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF V600E /VEGFR-2 inhibition, and computational studies

Ahmed Sabt iD, Mohammed A Khedr iD, Wagdy M Eldehna iD, Abdelsamed I Elshamy iD, Mohamed F Abdelhameed iD, Rasha M Allam iD, Rasha Z Batran iD

RSC Advances · 2024 · 14 (9) · 5907-5925

DOI: 10.1039/d4ra00157e ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Advances, 2024. Verfasst von Ahmed Sabt und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt ra…. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New pyrazolylindolin-2-one linked coumarin derivatives were designed as dual BRAF V600E /VEGFR-2 inhibitors targeting melanoma cells A375. Docking simulation showed various interactions with the binding residues in BRAF V600E and VEGFR-2 active sites.

Autor:innen und Institutionen

  • Chemistry of Natural Compounds Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre Dokki Cairo 12622 Egypt rasha_batran@yahoo.com.
  • Department of Pharmaceutical Chemistry, College of Pharmacy, Kuwait University Safat 13110 Kuwait.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Helwan University 11795 Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University Kafrelsheikh 33516 Egypt.
  • Pharmacology Department, Medical and Clinical Research Institute, National Research Centre Dokki Cairo 12622 Egypt.

ORCID-Profile: Ahmed Sabt, Mohammed A Khedr, Wagdy M Eldehna, Abdelsamed I Elshamy, Mohamed F Abdelhameed, Rasha M Allam, Rasha Z Batran

Zitieren

APA

Sabt, A., Khedr, M. A., Eldehna, W. M., Elshamy, A. I., Abdelhameed, M. F., Allam, R. M., & Batran, R. Z. (2024). New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF V600E /VEGFR-2 inhibition, and computational studies. RSC Advances, 14(9), 5907-5925. https://doi.org/10.1039/d4ra00157e

Vancouver

Sabt A, Khedr MA, Eldehna WM, Elshamy AI, Abdelhameed MF, Allam RM, et al. New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF V600E /VEGFR-2 inhibition, and computational studies. RSC Advances. 2024;14(9):5907-5925. doi:10.1039/d4ra00157e

BibTeX
@article{Sabt2024,
  author = {Sabt, Ahmed and Khedr, Mohammed A and Eldehna, Wagdy M and Elshamy, Abdelsamed I and Abdelhameed, Mohamed F and Allam, Rasha M and Batran, Rasha Z},
  title = {New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF V600E /VEGFR-2 inhibition, and computational studies},
  journal = {RSC Advances},
  year = {2024},
  volume = {14},
  number = {9},
  pages = {5907--5925},
  doi = {10.1039/d4ra00157e}
}
Kostenlos starten →